Airain Ltd’s Microbot Medical MBOT Stock Holding History

Airain Ltd’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-19	Closed	-$12K	–	962
2015 Q3	$12K	Buy	+19	New	+$14.4K	﹤0.01%	814

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Airain Ltd's MBOT Position: Q4 2015 in Review

Airain Ltd sold out of Microbot Medical (MBOT) in Q4 2015, closing a stake of 19 shares — an estimated $12K sold.

Airain Ltd first reported a position in MBOT in Q3 2015 and held it in 1 quarter. The position peaked at $12K in Q3 2015. 33 funds tracked by Wall St. Rank hold MBOT as of Q4 2015.

Airain Ltd reported no remaining Microbot Medical position as of Q4 2015 after selling out during the quarter.
Airain Ltd sold 19 Microbot Medical shares in Q4 2015, an estimated $12K.
Airain Ltd first reported a position in Microbot Medical in Q3 2015 and held it in 1 quarter.
Airain Ltd's Microbot Medical position peaked at $12K in Q3 2015.
33 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2015.

Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.